Create a 5% bio-engineered liver mass in order to develop “implantable liver tissue” for the treatment of inherited hepatic metabolic disorders.
PROJECT BACKGROUND
In this case the aim is to create a larger bio-engineered liver mass of the same volume of that used in living donor transplantation. This represents the ultimate goal of the EILF Bio-engineered Liver Initiative Strategy and is directed at increasing the possibility of spontaneous recovery of liver function and/or allowing a sufficient “bridge” time for whole organ transplantation